Rafferty Asset Management, LLC Verastem, Inc. Transaction History

Rafferty Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.06 - $2.1 $599,495 - $1.19 Million	-565,562 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.05 - $3.2 $272,155 - $424,828	132,759 Added 30.67%	565,562 $1.16 Million
Q3 2021 Nov 10, 2021	BUY	$2.54 - $4.07 $492,749 - $789,563	193,996 Added 81.24%	432,803 $1.33 Million
Q2 2021 Aug 10, 2021	BUY	$2.57 - $4.85 $613,733 - $1.16 Million	238,807 New	238,807 $972,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.